Prognostic factors of progesterone resistance in symptomatic adenomyosis: impact of lesion localization on treatment outcome of levonorgestrel intrauterine system
Abstract Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment response. However, the clinical characteristics of p...
Saved in:
| Main Authors: | Daiki Hiratsuka, Mitsunori Matsuo, Chihiro Ishizawa, Yamato Fukui, Takehiro Hiraoka, Shizu Aikawa, Gentaro Izumi, Miyuki Harada, Osamu Wada-Hiraike, Yutaka Osuga, Yasushi Hirota |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | BMC Women's Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12905-025-03817-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical treatment for adenomyosis: long term use of progestins
by: Silvia Vannuccini, et al.
Published: (2025-12-01) -
High-intensity focused ultrasound combined with hysteroscopic insertion of levonorgestrel-releasing intrauterine system for intrinsic adenomyosis: a retrospective observational study
by: Yanjun Kang, et al.
Published: (2025-12-01) -
Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta-analysis of 19 randomized controlled trials
by: Y. Sun, et al.
Published: (2020-12-01) -
Effect of COVID-19 Vaccine in Women with Adenomyosis and Endometriosis
by: Anjeza Xholli, et al.
Published: (2023-12-01) -
Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women
by: Sofie Orlov, et al.
Published: (2022-05-01)